← Leaderboards
Michael P Madaio
University Of Pennsylvania
$4,636,695
Attributed
$4,978,695
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $245.7K · FY2005–17$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,791,198 · 7
By mechanism
R01$2,520,099 · 3
P50$2,299,963 · 2
T32$1,566,886 · 1
R21$404,250 · 1
Top collaborators
- Rudolf Lucas3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- David L Gasser$5,974,420
- Eric G Neilson$3,078,817
- Alan D Schreiber$14,108,241
- Steven Mark Albelda$22,046,338
- Michael J Crawford$816,069
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseProtein SequenceGlomerulonephritisImmunoglobulin GAutoantibodyNephritisSystemic Lupus ErythematosusMonoclonal AntibodyCytokineAntigen Antibody ReactionKidneyAdverse EffectsIn VitroAnti-InflammatoryIn VivoInflammationEpitopesInflammatoryAntibody FormationInjuryImmuneAntibodiesAnti-Inflammatory AgentsBase
Grant awards (24)
Novel peptide-based strategy to inhibit deleterious TNF signaling in nephrotoxic nephritis$228,000
R01 · FY2017 · DK
Novel peptide-based strategy to inhibit deleterious TNF signaling in nephrotoxic nephritis$228,000
R01 · FY2016 · DK
Novel peptide-based strategy to inhibit deleterious TNF signaling in nephrotoxic nephritis$228,000
R01 · FY2015 · DK
Modified Human Anti-a(3) IV Antibodies for Drug Delivery in Nephritis$220,500
R21 · FY2010 · DK · contact PI
Modified Human Anti-a(3) IV Antibodies for Drug Delivery in Nephritis$183,750
R21 · FY2009 · DK · contact PI
Molecular Analysis of Human Anti-GBM Antibodies$245,677
R01 · FY2005 · DK
RENAL RESEARCH TRAINING PROGRAM$302,453
T32 · FY2004 · DK
Molecular Analysis of Human Anti-GBM Antibodies$245,677
R01 · FY2004 · DK
RENAL RESEARCH TRAINING PROGRAM$368,916
T32 · FY2003 · DK
Molecular Analysis of Human Anti-GBM Antibodies$245,677
R01 · FY2003 · DK
MOLECULAR MECHANISMS OF RENAL INJURY$362,501
P50 · FY2002 · DK
RENAL RESEARCH TRAINING PROGRAM$304,727
T32 · FY2002 · DK
Molecular Analysis of Human Anti-GBM Antibodies$302,735
R01 · FY2002 · DK
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES$159,355
P50 · FY2002 · DK
MOLECULAR ANALYSIS OF HUMAN ANTIGBM ANTIBODIES$39,625
R01 · FY2002 · DK
MOLECULAR MECHANISMS OF RENAL INJURY$725,001
P50 · FY2001 · DK
RENAL RESEARCH TRAINING PROGRAM$335,729
T32 · FY2001 · DK
IMMUNOLOGIC MECHANISM IN LUPUS NEPHRITIS$251,902
R01 · FY2001 · DK
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES$159,355
P50 · FY2001 · DK
MOLECULAR MECHANISMS OF RENAL INJURY$725,001
P50 · FY2000 · DK
MOLECULAR ANALYSIS OF HUMAN ANTIGBM ANTIBODIES$257,949
R01 · FY2000 · DK
RENAL RESEARCH TRAINING PROGRAM$255,061
T32 · FY2000 · DK
IMMUNOLOGIC MECHANISM IN LUPUS NEPHRITIS$246,857
R01 · FY2000 · DK
NUCLEAR LOCALIZATION OF NEPHRITOGENIC ANTI-DNA ANTIBODIES$168,750
P50 · FY2000 · DK